MRNA · Categories · Downgrades
MRNA - Analyst downgrades
Moderna Inc. (MRNA) analyst downgrades - real-time wire coverage filtered to Downgrades only.
Recent Downgrades for MRNA
- Moderna downgraded by Barclays with a new price targetBarclays downgraded Moderna from Overweight to Equal Weight and set a new price target of $45.00 from $111.00 previously
- Moderna downgraded by Goldman with a new price targetGoldman downgraded Moderna from Buy to Neutral and set a new price target of $51.00 from $99.00 previously
- Moderna downgraded by ArgusArgus downgraded Moderna from Buy to Hold
- Moderna downgraded by Jefferies with a new price targetJefferies downgraded Moderna from Buy to Hold and set a new price target of $65.00 from $120.00 previously
- Moderna downgraded by JP Morgan with a new price targetJP Morgan downgraded Moderna from Neutral to Underweight and set a new price target of $70.00 from $88.00 previously
- Moderna downgraded by OppenheimerOppenheimer downgraded Moderna from Outperform to Perform
- Moderna downgraded by RBC Capital Mkts with a new price targetRBC Capital Mkts downgraded Moderna from Outperform to Sector Perform and set a new price target of $90.00 from $125.00 previously
- Moderna downgraded by HSBC Securities with a new price targetHSBC Securities downgraded Moderna from Hold to Reduce and set a new price target of $86.00 from $75.00 previously
- Moderna downgraded by Deutsche Bank with a new price targetDeutsche Bank downgraded Moderna from Hold to Sell and set a new price target of $60.00 from $125.00 previously
- Moderna downgraded by TD Cowen with a new price targetTD Cowen downgraded Moderna from Outperform to Market Perform and set a new price target of $125.00 from $145.00 previously
- Moderna downgraded by Deutsche Bank with a new price targetDeutsche Bank downgraded Moderna from Buy to Hold and set a new price target of $125.00
- Moderna downgraded by SVB Securities with a new price targetSVB Securities downgraded Moderna from Market Perform to Underperform and set a new price target of $93.00 from $111.00 previously
- Moderna downgraded by Chardan Capital Markets with a new price targetChardan Capital Markets downgraded Moderna from Buy to Neutral and set a new price target of $191.00 from $186.00 previously
- Moderna downgraded by OppenheimerOppenheimer downgraded Moderna from Outperform to Perform
- Moderna downgraded by Piper Sandler with a new price targetPiper Sandler downgraded Moderna from Overweight to Neutral and set a new price target of $445.00 from $246.00 previously
- Moderna downgraded by B of A Securities with a new price targetB of A Securities downgraded Moderna from Neutral to Underperform and set a new price target of $150.00
- Moderna downgraded by BofA SecuritiesBofA Securities downgraded Moderna from Neutral to Underperform